Geode Capital Management, LLC Kintara Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.14 - $0.5 $29,455 - $105,196	-210,393 Reduced 37.01%	358,026 $99,000
Q1 2022 May 13, 2022	BUY	$0.31 - $0.55 $15,640 - $27,749	50,453 Added 9.74%	568,419 $226,000
Q4 2021 Feb 11, 2022	BUY	$0.51 - $1.04 $115,210 - $234,938	225,902 Added 77.35%	517,966 $264,000
Q3 2021 Nov 12, 2021	BUY	$0.82 - $2.3 $11,559 - $32,423	14,097 Added 5.07%	292,064 $251,000
Q2 2021 Aug 13, 2021	BUY	$1.26 - $2.4 $158,612 - $302,119	125,883 Added 82.77%	277,967 $630,000
Q1 2021 May 12, 2021	BUY	$1.32 - $2.74 $200,750 - $416,710	152,084 New	152,084 $264,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.